Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors

NCT01603004 · clinicaltrials.gov ↗

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Neuroendocrine Cancer

Interventions

OTHER: MRI

Sponsor

Memorial Sloan Kettering Cancer Center